Brought to you by 
Abbott buys BASF's Knoll, pharmaceutical units
Dec 2000
Executive Summary
Abbott Laboratories is paying $6.9bn in cash for BASF's pharmaceutical business, including all Knoll divisions. It paid $650mm from available cash and is financing the remaining $6.35bn with debt at rates between 6-6.5%.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com